Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat

Endocrinology
B A CrippesG A Nickols

Abstract

The cell surface integrin, alphaVbeta3, is important for the attachment of osteoclasts to bone matrix and the subsequent resorption of bone. The present study was designed to determine the effects of F11, a monoclonal antibody to the rat beta3 subunit, on calcium mobilization in a rat model of bone resorption. Male Sprague Dawley rats became hypocalcemic within 18 h after thyroparathyroidectomy. Synthetic PTH-related protein (PTHrP(1-34)) administered to control rats caused serum calcium to return to normal. Anti-beta3 treatment of rats after thyroparathyroidectomy inhibited the calcemic response to PTHrP by 65%. Circulating F11 was biologically active as demonstrated by osteoclast retraction and by the inhibition of adenosine diphosphate-induced platelet aggregation via inhibition of the platelet integrin alphaIIbbeta3 in ex vivo assays. F11 antibody was localized by immunohistological staining to osteoclasts in long bones, suggesting that the mechanism of action of the antibody was via a direct effect upon osteoclasts. Echistatin and calcitonin also inhibited calcemic responses to PTHrP in this in vivo model, whereas an isotype-matched, control antibody was ineffective. These studies provide the first direct evidence in vivo ...Continue Reading

Citations

Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·H YoshitakeM Noda
Oct 1, 1996·Annals of the Rheumatic Diseases·S Patel
Jul 19, 2011·The Journal of Clinical Investigation·Noam LevaotRobert Rottapel
Jan 23, 1999·The Journal of Clinical Investigation·K M Hodivala-DilkeR O Hynes
May 7, 2011·Theranostics·Melissa MillardNouri Neamati
Feb 24, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M W LarkM Gowen
Sep 5, 2006·Reviews in Endocrine & Metabolic Disorders·Angela Bruzzaniti, Roland Baron
Sep 29, 2011·Modern Rheumatology·Ichiro NakamuraTatsuo Suda
Sep 21, 2010·Bone·Jochen G SchneiderKatherine N Weilbaecher
Oct 9, 2003·British Journal of Haematology·Yukihiko SaekiIchiro Kawase
Sep 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B J VottaM Gowen
Jan 27, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·A TetiK A Hruska
Oct 31, 2007·Journal of Bone and Mineral Metabolism·Ichiro NakamuraGideon A Rodan
Jan 30, 2013·Nature Reviews. Endocrinology·Pierre J Marie
Apr 8, 1998·The American Journal of Physiology·R G ErbenM Stangassinger
Dec 5, 2000·The Journal of Biological Chemistry·L T DuongG A Rodan
Apr 20, 2002·The Journal of Biological Chemistry·Richard C D'AlonzoNicola C Partridge
Aug 4, 2001·Best Practice & Research. Clinical Rheumatology·B R MacDonald, M Gowen
Oct 3, 2003·Journal of Medicinal Chemistry·Luciana MarinelliHorst Kessler
Dec 13, 2002·Journal of Medicinal Chemistry·Bradley P FeustonSevgi B Rodan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.